Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer

Author:

Kelly Ronan J.1,Ajani Jaffer A.1ORCID,Kuzdzal Jaroslaw1,Zander Thomas1,Van Cutsem Eric1,Piessen Guillaume1ORCID,Mendez Guillermo1,Feliciano Josephine1,Motoyama Satoru1,Lièvre Astrid1,Uronis Hope1,Elimova Elena1,Grootscholten Cecile1,Geboes Karen1,Zafar Syed1,Snow Stephanie1,Ko Andrew H.1,Feeney Kynan1,Schenker Michael1,Kocon Piotr1,Zhang Jenny1,Zhu Lili1,Lei Ming1,Singh Prianka1,Kondo Kaoru1,Cleary James M.1,Moehler Markus1

Affiliation:

1. From the Charles A. Sammons Cancer Center at Baylor University Medical Center, Dallas (R.J.K.), and the University of Texas M.D. Anderson Cancer Center, Houston (J.A.A.); Jagiellonian University Medical College, John Paul II Hospital, Krakow, Poland (J.K., P.K.); the University Hospital Cologne, Department of Internal Medicine, Center for Integrated Oncology Aachen–Bonn–Cologne–Duesseldorf, Gastrointestinal Cancer Group Cologne, Cologne (T.Z.), and University Medical Center of Johannes...

Funder

Bristol Myers Squibb

Publisher

Massachusetts Medical Society

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3